ALPHA TEKNOVA INC Share Price Today: Live Updates & Key Insights

ALPHA TEKNOVA INC share price today is $2.67, up -1.48%. The stock opened at $2.75 against the previous close of $2.71, with an intraday high of $2.76 and low of $2.645.

ALPHA TEKNOVA INC Share Price Chart

ALPHA TEKNOVA INC

us-stock
To Invest in {{usstockname}}
us-stock

ALPHA TEKNOVA INC Share Price Performance

$2.67 -0.0148(-1.48%) TKNO at 13 Mar 2026 03:31 PM Drug Manufacturers - Specialty & Generic
Lowest Today 2.645
Highest Today 2.76
Today’s Open 2.75
Prev. Close 2.71
52 Week High 7.48
52 Week Low 1.91
Day’s Range: Low 2.645 High 2.76
52-Week Range: Low 1.91 High 7.48
1 day return -
1 Week return +27.01
1 month return +34.67
3 month return -41.86
6 month return -40.7
1 year return -48.46
3 year return -22.09
5 year return -89.26
10 year return -

ALPHA TEKNOVA INC Institutional Holdings

UBS Group AG 2.80

Roubaix Capital, LLC 1.86

Balyasny Asset Management LLC 1.84

BlackRock Inc 1.30

Vanguard Group Inc 1.11

Vanguard Total Stock Mkt Idx Inv 0.61

Conestoga Capital Advisors, LLC 0.59

Royce & Associates, LP 0.55

Conestoga Micro Cap Growth 0.53

Geode Capital Management, LLC 0.53

iShares Russell 2000 ETF 0.47

Bank of America Corp 0.42

Royce Micro-Cap Trust 0.34

State Street Corp 0.29

Bank of New York Mellon Corp 0.22

Vanguard Institutional Extnd Mkt Idx Tr 0.21

Fidelity Small Cap Index 0.20

Morgan Stanley - Brokerage Accounts 0.20

Northern Trust Corp 0.19

EHP Funds Inc. 0.16

Royce Micro-Cap Invmt 0.16

iShares Russell 2000 Growth ETF 0.16

iShares Biotechnology ETF 0.16

Bridgeway Capital Management, LLC 0.15

KESTRA PRIVATE WEALTH SERVICES, LLC 0.15

Divisadero Street Capital Management, LP 0.15

Bridgeway Ultra-Small Company Market 0.14

Mt Lucas Management LP 0.13

Apollo Management Holdings LP 0.12

Two Sigma Investments LLC 0.11

Fidelity Extended Market Index 0.11

Vanguard Russell 2000 ETF 0.10

State St Russell Sm Cap® Indx SL Cl I 0.07

iShares Nasdaq US Biotech ETF USD Acc 0.07

Blackrock Extended Mkt Fund CF 0.06

Conestoga Discovery Institutional 0.06

Fidelity Nasdaq Composite Index 0.06

iShares Micro-Cap ETF 0.05

Extended Equity Market Fund K 0.05

Schwab Small Cap Index 0.05

ALPHA TEKNOVA INC Market Status

Strong Buy: 3

Buy: 0

Hold: 2

Sell: 0

Strong Sell: 0

ALPHA TEKNOVA INC Fundamentals

Market Cap 145.22 M

PB Ratio 2.1116

PE Ratio 0.0

Enterprise Value 152.15 M

Total Assets 103.58 M

Volume 103557

ALPHA TEKNOVA INC Company Financials

Annual Revenue FY23:36708000 36.7M, FY22:41420000 41.4M, FY21:36893000 36.9M, FY20:31297000 31.3M, FY19:20094000 20.1M

Annual Profit FY23:11071000 11.1M, FY22:17476000 17.5M, FY21:17621000 17.6M, FY20:17755000 17.8M, FY19:8574000 8.6M

Annual Net worth FY23:-39418000 -39.4M, FY22:-47468000 -47.5M, FY21:-9803000 -9.8M, FY20:3570000 3.6M, FY19:-1305000 -1.3M

Quarterly Revenue Q3/2025:10454000 10.5M, Q2/2025:10287000 10.3M, Q1/2025:9795000 9.8M, Q3/2024:9576000 9.6M, Q2/2024:9614000 9.6M

Quarterly Profit Q3/2025:3206000 3.2M, Q2/2025:3984000 4.0M, Q1/2025:3007000 3.0M, Q3/2024:90000 0.1M, Q2/2024:2804000 2.8M

Quarterly Net worth Q3/2025:-4286000 -4.3M, Q2/2025:-3570000 -3.6M, Q1/2025:-4645000 -4.6M, Q3/2024:-7565000 -7.6M, Q2/2024:-5364000 -5.4M

About ALPHA TEKNOVA INC & investment objective

Company Information Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company' primary products include pre-poured media plates for cell growth and cloning; liquid microbial culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It provides lab essentials which provides chemical formulations for use in biological research and drug discovery; and clinical solutions, a custom product used in the development and production of protein therapies, gene therapies, mRNA vaccines, and diagnostic kits. The company serves its products to life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, as well as academic and government research institutions. Alpha Teknova, Inc. was founded in 1996 and is headquartered in Hollister, California.

Organisation Drug Manufacturers - Specialty & Generic

Employees 158

Industry Drug Manufacturers - Specialty & Generic

CEO Mr. Stephen Gunstream

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right